Equities

Beta Drugs Ltd

Beta Drugs Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)2,075.00
  • Today's Change5.00 / 0.24%
  • Shares traded1.90k
  • 1 Year change+70.38%
  • Beta1.1742
Data delayed at least 15 minutes, as of Nov 13 2024 05:41 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue2,9572,2711,838
OPERATING EXPENSES
Cost of revenue total1,8121,3001,122
Selling, general and admin. expenses, total546437289
Depreciation/amortization9810473
Unusual expense(income)00.040.04
Other operating expenses, total00.000
Total operating expense2,4561,8411,484
Operating income501430354
Other, net1.33(0.44)1.51
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes488411343
Provision for income taxes12310395
Net income after taxes364307248
Minority interest------
Net income before extra. Items364307248
Total extraordinary items------
Net income364307248
Inc.avail. to common excl. extra. Items364307248
Inc.avail. to common incl. extra. Items364307248
EPS RECONCILIATION
Basic/primary weighted average shares9.619.619.61
Basic/primary eps excl. extra items383226
Basic/primary eps incl. extra items383226
Dilution adjustment------
Diluted weighted average shares9.619.619.61
Diluted eps excl. extra items383226
Diluted eps incl. extra items383226
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental272318
SUPPLEMENTAL INCOME
Depreciation, supplemental7410070
Total special items00.040.04
NORMALISED INCOME
Normalized income before taxes488411343
Effect of special items on income taxes00.010.01
Income tax excluding impact of special items12310395
Normalized income after tax364307248
Normalized income avail. to common364307248
Basic normalized EPS383226
Diluted normalized EPS383226
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.